Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells

Dig Dis Sci. 2001 Sep;46(9):1871-81. doi: 10.1023/a:1010622828502.

Abstract

Phospholipase A2 (PLA2) has been suggested in the pathogenesis of acute pancreatitis, in part through the PLA2-generated phospholipid by-products, most notably lysophosphatidylcholine (lyso-PC). The effects of lyso-PC on pancreatic acinar cells other than necrosis are poorly characterized. Recent studies have suggested a role of the activation of transcription factors such as nuclear factor kappa B (NF-kappaB) for the pathogenesis of acute pancreatitis. Here we examined the effects of lyso-PC on the activation of transcriptional factors in rat pancreatic AR42J cells. Lyso-PC induced apoptosis at concentrations > or = 10 microM. At 10 and 25 microM, lyso-PC increased the NF-kappaB- and activator protein-1 (AP-1)-specific DNA binding activity as determined by electrophoretic mobility shift assay. Lyso-PC also increased the transcriptional activity of NF-kappaB and AP-1 as assessed by luciferase assay. Lyso-PC increased the mRNA level of pancreatitis-associated protein-I and c-jun. Lyso-PC activated three classes of mitogen activated protein kinases: extracellular signal-regulated kinase 1/2, c-Jun NH2-terminal kinase/stress-activated protein kinase and p38 kinases. Activation of transcription factors by lyso-PC was not altered by a specific platelet activating factor receptor antagonist, TCV-309, suggesting that the activation was independent of the platelet activating factor receptor. These molecular events may suggest a novel role of lyso-PC for the modulation of acinar cell function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Apoptosis
  • Cells, Cultured
  • Cytotoxicity, Immunologic
  • Isoquinolines / pharmacology
  • Lysophosphatidylcholines / pharmacology*
  • NF-kappa B / physiology*
  • Pancreatitis / physiopathology*
  • Pancreatitis-Associated Proteins
  • Platelet Aggregation Inhibitors / pharmacology
  • Pyridinium Compounds / pharmacology
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tetrahydroisoquinolines*
  • Transcription Factor AP-1 / physiology*

Substances

  • Isoquinolines
  • Lysophosphatidylcholines
  • NF-kappa B
  • Pancreatitis-Associated Proteins
  • Platelet Aggregation Inhibitors
  • Pyridinium Compounds
  • REG3A protein, human
  • Tetrahydroisoquinolines
  • Transcription Factor AP-1
  • TCV 309